mappp.ipro.orgIPRO MAPPP app

This site utilizes javascript for its functionality. You must enable javascript in order for it to function. We have detected that you are running an usupported IE version (9 or lower). MAPPP! Welcome to IPRO's Management of Anticoagulation in the Peri-Procedural Period app. Click here to try the web-based version now! Despite the considerable efficacy of antithrombotics and the increased number of oral anticoagulants now available, preventable bleeding and thrombotic events are still unacceptably common. While recently marketed agents require less laboratory monitoring, problems with the clinical management of anticoagulated patients persist, particularly in the peri-procedural period. Surgery and invasive medical interventions increase the risk of bleeding, while withholding anticoagulants increases the risk of thrombosis due to the underlying condition(s) for which anticoagulation was originally prescribed. The clinical team must therefore balance these competing risks and make educated decisions regarding the decision to interrupt oral anticoagulation for a medical procedure and, if interrupted, whether to "bridge" anticoagulation with injectable anticoagulants, such as low molecular weight heparin (LMWH) in warfarin treated patients. This guide is intended to: Assist clinicians in the simultaneous evaluation of procedure-related bleeding risk and underlying risk of thrombosis Guide decisions regarding the interruption of anticoagulation and the use of anticoagulant "bridging" Provide detailed guidance for drug dosing and laboratory monitoring in the peri-procedural period Encourage clear communication between clinicians involved in prescribing anticoagulants and performing invasive procedures This material was created in April 2014 by the multidisciplinary members of the Peri-Procedural Task Force of the New York State Anticoagulation Coalition and IPRO, the Medicare Quality Improvement Organization for New York State, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents do not necessarily reflect CMS policy. 10SOW-NY-AIM-7.3-14-01 Browser Requirements To view this app in your browser properly, you must have Javascript enabled as well as use one of the supported browsers: Google Chrome - latest version Mozilla Firefox - latest version Microsoft Internet Explorer - version 10+ Microsoft Edge - version 12+ Event Enduring Webinar: Management of Anticoagulation in the Peri-Procedural Period (MAPPP) App: Overview, Instructions and Case Studies Date of original webinar: May 12, 2017 Presenters: Alex C Spyropoulos, MD, FACP, FCCP, FRCPC Professor of Medicine, Hofstra Northwell School of Medicine Professor, The Merinoff Center for Patient-Oriented Research -The Feinstein Institute for Medical Research Director, Anticoagulation and Clinical Thrombosis Services Northwell Health at Lenox Hill Hospital Jessica Cohen, MD Division of Hospital Medicine, North Shore University Hospital, Department of Medicine Assistant Professor of Medicine, Hofstra Northwell School of Medicine Intended Audience: physicians, pharmacists, nurses, or any clinician responsible for anticoagulation management Program Objectives: Assist clinicians in the simultaneous evaluation of procedure-related bleeding risk and underlying risk of thrombosis Guide decisions regarding the interruption of anticoagulation and the use of anticoagulant “bridging” Provide detailed guidance for drug dosing and laboratory monitoring in the peri-procedural period Encourage clear communication between clinicians involved in prescribing anticoagulants and performing invasive procedures Download slides or view the webinar: Download slides for review and note taking while watching the webinar: MAPPP Education Webinar Slides Your system does not support the video tag. -- MAPPP Education Recorded Webinar (WRF version) MAPPP Education Recorded Webinar (WMV version) Patient Education Materials The patient education materials below provide information for patients on managing their anticoagulation therapy before, during, and after planned or elective surgical or invasive procedures. These materials can be used for patient education and knowledge assessment in any healthcare setting and were produced in collaboration with The National Blood Clot Alliance. Understanding anticoagulant risk prevention when surgery or other procedures are planned. - A patient’s guide to understanding their anticoagulation regimen may be altered due to a surgery or procedure. Additionally, the bottom of the form is for the patient to record their specific directions from the clinician. Risk Prevention Checklist Anticoagulation management: What to expect when surgery or other medical or dental procedures are planned. - A comprehensive description of anticoagulants and their use in patients, including before, during, and after procedures. Detailed Fact Sheet A quick reference of anticoagulation management, what to expect when surgery or other medical or dental procedures are planned. – A one page summary of the above comprehensive description. Document Snapshot Patient knowledge assessment. - After reading the educational materials about anticoagulation management when surgery or invasive procedures are planned, test your knowledge by answering the questions below. Share the results with your doctor or other healthcare provider. Knowledge Assessment For more patient centered information about blood clots: The National Blood Clot Alliance A non-profit, patient-led, voluntary health organization dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots. Stop The Clot Registration Instructions – Pre-registration Required Click or Copy and Paste this URL to your web browser: https://qualitynet.webex.com This should bring you to the QualityNet e-University webpage. Locate the event you wish to register for Click on Register, enter the requested information and click submit Once approved, you will receive a confirmation email with the meeting information and the Registration ID that will be used to log into the WebEx portion of the meeting. Please note, this email may go to your spam or junk folder. It will come from the email address messenger@webex.com . Webinar Connection Instructions Please join the event 15 minutes prior to the start time to ensure the automatic system set-up has been properly established. Instructions: Click or Copy and Paste this URL to your web browser: https://qualitynet.webex.com Locate the event you wish to join and click “Join” (located to the right of the event title) Enter your Registration ID as prompted (if the text boxes and “Join Now” button are inactive, refresh your web browser) Enter the password: IPRO The automatic system set-up should start at this point. If a dialogue box appears, click run. Please note, the automatic system set-up does take a few minutes to complete Dial in to the teleconference: (866) 206-7204; no access code needed If you have any questions or problems accessing the web portion of this meeting, please call the Ventech Solutions WebEx Helpline at 571-598-1988. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Medical Society of the State of New York (MSSNY) and IPRO. MSSNY is accredited by ACCME to provide continuing medical education for physicians. The Medical Society of the State of New York designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. For more information contact: Anne Myrka, IPRO Director, Drug Safety (518) 320-3591 anne.myrka@area-i.hcqis.org -- About IPRO IPRO is a non-profit organization that works with government age...